Bank of America Corp DE cut its holdings in Dyne Therapeutics, Inc. (NASDAQ:DYN – Free Report) by 58.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional…